drugset / Trial / NCT05499936
68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)
NaSingle-groupOpen-labelDiagnostic
Summary
This study was used to study the diagnostic value of 68Ga-FAPI, a novel fibroblast activating inhibitor, in metastatic adenoid cystic carcinoma（ACC）
Timeline
- Start
- 2021-10-01
- Primary completion
- 2022-10-01
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAPI GA-68 | Diagnostic / imaging agent | 2 unknown | — |
| Subject | FAPI GA-68 | Diagnostic / imaging agent | 4 unknown | — |